NANO-X IMAGING LTD

NNOX, which stands for Nano-X Imaging Ltd., is a medical imaging technology company. It develops and commercializes a digital X-ray source and related systems intended to make medical imaging more accessible and lower cost. The company's core focus includes its Nanox.ARC system and teleradiology services. Its business spans hardware, software, and imaging services, primarily targeting healthcare providers and markets where access to radiology is limited.

NNOX stock is listed on the Nasdaq Global Select Market under the ticker symbol NNOX. It is also traded on the Tel Aviv Stock Exchange, reflecting the company's Israeli roots. Investors in the U.S. can buy and sell shares through standard brokerage accounts during Nasdaq trading hours. The exact market and exchange details are shown on the stock page.

NNOX has historically shown high volatility compared with broad market indices. Its share price has experienced large swings due to a relatively small public float, limited revenue history, and sensitivity to news about regulatory clearances, commercialization progress, and financing activities. For current measures of volatility, such as beta or recent price swings, refer to the latest data displayed on the NNOX stock page.

Valuation for NNOX is challenging using traditional earnings-based metrics because the company has a limited revenue base and reported losses. Investors often consider price-to-sales, price-to-book, enterprise value, and cash position instead. Comparing these metrics to peers in medical technology and imaging can provide context. Since these figures change with market prices and financial reports, use the latest valuation data shown on the NNOX page.

NNOX does not pay regular dividends. The company reinvests its capital into research, development, and commercialization of its medical imaging technology. As a growth-stage medical technology firm, it prioritizes funding operations and expansion over returning cash to shareholders. Therefore, dividend-focused investors typically look elsewhere. Any future changes to this policy would be announced in company filings and on the stock page.

Key risks for NNOX include uncertain commercialization of its imaging technology, regulatory and reimbursement hurdles, competitive pressures in medical imaging, and the need for additional capital. The company has a history of losses and may not achieve profitability. Its share price can also be sensitive to financing terms, dilution, and shifts in investor sentiment toward pre-revenue or early-stage medtech companies. Review the latest risk factors in company filings for a full picture.